KDR and Hypertension: The adrenergic system and the renin–angiotensin–aldosterone axis may also be involved in the development of treatment-emerged hypertension (TE-HTN), but different findings suggest that this is not the primary mechanism associated with hypertension caused by VEGFR inhibition [20,68,73,74].